Dhibiti Malaria Project

Over 45 million people are at risk of malaria in Tanzania due to the suitable climate and topography for transmission. Plasmodium falciparum is responsible for 96% of malaria infections with the remaining 4% attributed to other Plasmodia, mainly Plasmodium malariae and Plasmodium ovale. The major malaria vectors in most areas of the Mainland are members of the Anopheles funestus group (56.3%), followed by Anopheles arabiensis (24.9%) and Anopheles gambiae (18.8%). Multiple data sources from both routine Health Facility data (e.g., data of pregnant women tested during their first antenatal care [ANC] visit), population-based surveys (e.g., Tanzania Malaria Indicator Surveys [TMIS], Tanzania Demographic and Health Surveys), and parasitological surveys (e.g., School Malaria Parasitological Surveys) confirm high malaria transmission heterogeneity. Zanzibar is on the brink of eliminating malaria. For over a decade, the archipelago has experienced malaria prevalence of less than 1%, with the most recent TMIS showing a prevalence of 0.2% in children under the age of five according to malaria rapid diagnostic testing (mRDT) Tanzania, with assistance from the President’s Malaria Initiative (PMI) will use Dhibiti Malaria’s approach to increase access to quality malaria prevention, diagnosis, and treatment services in high burden regions on Tanzania, with assistance from the President’s Malaria Initiative is supporting capacity building and skills development to Health Community Practitioners to improve quality of malaria services at the facility level. the Mainland and regions approaching elimination on Zanzibar. The approach will build on the success of recent USAID and PMI investments, including PMI Impact Malaria (IM), Okoa Maisha Dhibiti Malaria (OMDM), and USAID Boresha Afya.

Project details

Drug-based Strategies
Epidemiology
Health Systems & Op. Research
Health Workforce
Impact of Interventions
Surveillance

Aug 2022 — Aug 2027

$27M

Tanzania